United States · FDA National Drug Code directory

AMPHETAMINE

Source ingredient · 23 source records

Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.

United States · Source reference 70165-005_512c5af5-6bf8-ace1-e063-6394a90ad807

Adzenys XR-ODT

TABLET, ORALLY DISINTEGRATING / Neos Therapeutics Brands, LLC

United States · Source reference 70165-010_512c5af5-6bf8-ace1-e063-6394a90ad807

Adzenys XR-ODT

TABLET, ORALLY DISINTEGRATING / Neos Therapeutics Brands, LLC

United States · Source reference 70165-015_512c5af5-6bf8-ace1-e063-6394a90ad807

Adzenys XR-ODT

TABLET, ORALLY DISINTEGRATING / Neos Therapeutics Brands, LLC

United States · Source reference 70165-020_512c5af5-6bf8-ace1-e063-6394a90ad807

Adzenys XR-ODT

TABLET, ORALLY DISINTEGRATING / Neos Therapeutics Brands, LLC

United States · Source reference 70165-025_512c5af5-6bf8-ace1-e063-6394a90ad807

Adzenys XR-ODT

TABLET, ORALLY DISINTEGRATING / Neos Therapeutics Brands, LLC

United States · Source reference 70165-030_512c5af5-6bf8-ace1-e063-6394a90ad807

Adzenys XR-ODT

TABLET, ORALLY DISINTEGRATING / Neos Therapeutics Brands, LLC

United States · Source reference 0480-3315_074770c9-d04b-4ad5-b346-76f9c121a44d

Amphetamine

TABLET, ORALLY DISINTEGRATING / Teva Pharmaceuticals, Inc.

United States · Source reference 0480-3316_074770c9-d04b-4ad5-b346-76f9c121a44d

Amphetamine

TABLET, ORALLY DISINTEGRATING / Teva Pharmaceuticals, Inc.

United States · Source reference 0480-3317_074770c9-d04b-4ad5-b346-76f9c121a44d

Amphetamine

TABLET, ORALLY DISINTEGRATING / Teva Pharmaceuticals, Inc.

United States · Source reference 0480-3318_074770c9-d04b-4ad5-b346-76f9c121a44d

Amphetamine

TABLET, ORALLY DISINTEGRATING / Teva Pharmaceuticals, Inc.

United States · Source reference 0480-3319_074770c9-d04b-4ad5-b346-76f9c121a44d

Amphetamine

TABLET, ORALLY DISINTEGRATING / Teva Pharmaceuticals, Inc.

United States · Source reference 0480-3320_074770c9-d04b-4ad5-b346-76f9c121a44d

Amphetamine

TABLET, ORALLY DISINTEGRATING / Teva Pharmaceuticals, Inc.

United States · Source reference 62542-005_3f9283a3-e922-36ca-e063-6394a90a409d

Amphetamine Extended-Release

TABLET, ORALLY DISINTEGRATING / Neos Therapeutics, LP

United States · Source reference 62542-010_3f9283a3-e922-36ca-e063-6394a90a409d

Amphetamine Extended-Release

TABLET, ORALLY DISINTEGRATING / Neos Therapeutics, LP

United States · Source reference 62542-015_3f9283a3-e922-36ca-e063-6394a90a409d

Amphetamine Extended-Release

TABLET, ORALLY DISINTEGRATING / Neos Therapeutics, LP

United States · Source reference 62542-020_3f9283a3-e922-36ca-e063-6394a90a409d

Amphetamine Extended-Release

TABLET, ORALLY DISINTEGRATING / Neos Therapeutics, LP

United States · Source reference 62542-025_3f9283a3-e922-36ca-e063-6394a90a409d

Amphetamine Extended-Release

TABLET, ORALLY DISINTEGRATING / Neos Therapeutics, LP

United States · Source reference 62542-030_3f9283a3-e922-36ca-e063-6394a90a409d

Amphetamine Extended-Release

TABLET, ORALLY DISINTEGRATING / Neos Therapeutics, LP

United States · Source reference 24478-106_32c90701-fe4a-4d5a-b3bb-e9ccf0416ece

DYANAVEL XR

TABLET, EXTENDED RELEASE / NextWave Pharmaceuticals, Inc

United States · Source reference 24478-108_32c90701-fe4a-4d5a-b3bb-e9ccf0416ece

DYANAVEL XR

TABLET, EXTENDED RELEASE / NextWave Pharmaceuticals, Inc

United States · Source reference 24478-109_32c90701-fe4a-4d5a-b3bb-e9ccf0416ece

DYANAVEL XR

TABLET, EXTENDED RELEASE / NextWave Pharmaceuticals, Inc

United States · Source reference 24478-110_32c90701-fe4a-4d5a-b3bb-e9ccf0416ece

DYANAVEL XR

TABLET, EXTENDED RELEASE / NextWave Pharmaceuticals, Inc

United States · Source reference 24478-102_32c90701-fe4a-4d5a-b3bb-e9ccf0416ece

Dyanavel XR

SUSPENSION, EXTENDED RELEASE / NextWave Pharmaceuticals, Inc

Browse ingredients in United States →
AMPHETAMINE | Molindra Medicines